Privilege escalation in N/a

CVE-2026-41085

Thermo Fisher Scientific Torrent Suite Dx through 5.14.2 has a privilege escalation vulnerability that may allow an authenticated user with limited access privileges to gain unauthorized administrator-level privileges through exploitation of specific system interfaces.

Vulnerability class: Privilege Escalation

Published · last modified .

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.004 (36.3th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 36th percentile — 36.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2026-41085: held from 0.003 to 0.004.

EPSS over last 30 days · oldest: 0.003 · newest: 0.004 · change: +0.002

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2026-41085?
CVE-2026-41085 is a high-severity vulnerability in N/a, classified under Improper Privilege Management. CVSS score: 8.8/10. Published 2026-05-18.
How severe is CVE-2026-41085?
High severity. CVSS v3 base score is 8.8 out of 10.